title: Systemic lupus erythematosus and refractory cytopenia: successful outcome with danazol.
authors.forename: Vishal
authors.initials: V
authors.lastname: Marwaha
authors.forename: Ashok
authors.initials: A
authors.lastname: Kumar
authors.forename: Rahul
authors.initials: R
authors.lastname: Grover
authors.forename: S
authors.initials: S
authors.lastname: Tiwari
authors.forename: V P
authors.initials: VP
authors.lastname: Chaudhary
mesh_terms: D003613:Danazol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology
chemical_list: D011239:Prednisolone; D003613:Danazol